Our Services
Medical Information
Helpful Resources
Published on: 10/22/2026
A high INR while taking warfarin means your blood is clotting more slowly than intended, which raises your risk of serious bleeding, and there are several factors to consider. Common contributors include a dosing error, new prescriptions or antibiotics, alcohol use, acute illness, thyroid or liver problems, and shifts in vitamin K intake from foods like leafy greens. Depending on how high the number is and whether you are bleeding, management may involve skipping or lowering a dose, taking vitamin K, or seeking emergency care, especially with unexplained bruising, nosebleeds that will not stop, blood in urine or stool, vomiting blood, or a severe headache. Target ranges differ by condition, so the specific numbers, red flags, and next steps are explained below and are worth reading in full before you make any changes.
Because a high INR can be caused by something as routine as a diet change or as urgent as internal bleeding, it helps to sort out what is happening right now, and a free, instant, online symptom check can help you review your symptoms in minutes and understand whether you should call your anticoagulation clinic or seek care immediately.
Last reviewed for medical accuracy: 10/22/2026
If you’re on warfarin, your doctor regularly checks your International Normalized Ratio (INR). An INR higher than your target range means your blood is taking too long to clot. While this doesn’t always lead to serious problems, it does raise your risk of bleeding. Understanding why your INR is high, what signs to watch for, and how to respond can help you stay safer on warfarin.
When your INR is above the target:
Dietary changes
Medication interactions
Illness and health changes
Dose mistakes
Other factors
Watch for these warning signs. If you notice any, act promptly:
Tip: Keeping a bleeding diary helps you notice small changes before they become serious.
Confirm the result
Contact your healthcare provider
Consider vitamin K
Monitor for bleeding
Do NOT self-treat with high doses of vitamin K without a doctor’s guidance—it can swing you to the clotting side.
Keep a consistent diet.
Review all medications and supplements.
Stick to your warfarin schedule.
Regular INR checks.
Maintain open communication.
High INR alone isn’t always an emergency—mildly elevated values can be managed with dose adjustments. However, seek immediate medical attention if you experience:
If in doubt, it’s safest to get checked. You might also try a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you decide if you need urgent care.
If you’re unsure whether your symptoms need immediate medical attention, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s quick, confidential, and may guide you on next steps.
Link:
free, online symptom check, using the doctor approved Ubie Symptom Checker
Managing a high INR on warfarin is about balance. You want to prevent clots without tipping too far toward bleeding. By understanding what affects your INR, recognizing warning signs, and taking prompt action, you can reduce risks and stay healthier.
Always speak to a doctor for any symptoms that could signal a life-threatening problem. Your healthcare team is your best resource for personalized advice and adjustments. Regular monitoring, open communication, and adherence to your treatment plan are key to safe, effective anticoagulation.
(References)
* Kierulf-Lassen C, Hvas AM, Poulsen BK. [Serious bleeding complications caused by warfarin with international normalized ratio 2.1]. Ugeskr Laeger. 2015 Jan 26;177(2A):52-3. PMID: 25612965.
* Reddy U, Mallepaddi NR, Chevassut TJ. High INR on warfarin. BMJ. 2015 Apr 9;350:h1282. doi: 10.1136/bmj.h1282. Epub 2015 Apr 9. PMID: 25858914.
* Barnes GD, Kong X, Cole D, Haymart B, Kline-Rogers E, Almany S, Dahu M, Ekola M, Kaatz S, Kozlowski J, Froehlich JB. Extended International Normalized Ratio testing intervals for warfarin-treated patients. J Thromb Haemost. 2018 Jul;16(7):1307-1312. doi: 10.1111/jth.14150. Epub 2018 Jun 6. PMID: 29763979.
* Can A, Castro VM, Dligach D, Finan S, Yu S, Gainer V, Shadick NA, Savova G, Murphy S, Cai T, Weiss ST, Du R. Elevated International Normalized Ratio Is Associated With Ruptured Aneurysms. Stroke. 2018 Sep;49(9):2046-2052. doi: 10.1161/STROKEAHA.118.022412. PMID: 30354989; PMCID: PMC6205738.
* Guimarães PO, Lopes RD, Alexander JH, Thomas L, Hellkamp AS, Hijazi Z, Hylek EM, Gersh BJ, Garcia DA, Verheugt FWA, Hanna M, Flaker G, Vinereanu D, Granger CB. International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin. J Thromb Thrombolysis. 2019 Jul;48(1):27-34. doi: 10.1007/s11239-019-01858-1. PMID: 30972712.
* Xue L, Zhang Y, Xie C, Zhou L, Liu L, Zhang H, Xu L, Song H, Lin M, Qiu H, Zhu J, Zhu Y, Zou J, Zhuang W, Xuan B, Chen Y, Fan Y, Wu D, Shen Z, Miao L. Relationship between warfarin dosage and international normalized ratio: a dose-response analysis and evaluation based on multicenter data. Eur J Clin Pharmacol. 2019 Jun;75(6):785-794. doi: 10.1007/s00228-019-02655-8. Epub 2019 Apr 29. PMID: 31037455.
* Li D, Luo ZY, Chen Y, Zhu H, Song GB, Zhou XM, Yan H, Zhou HH, Zhang W, Li X. LRP1 and APOA1 Polymorphisms: Impact on Warfarin International Normalized Ratio-Related Phenotypes. J Cardiovasc Pharmacol. 2020 Jul;76(1):71-76. doi: 10.1097/FJC.0000000000000834. PMID: 32282500.
* Minhaj FS, Leonard JB, Seung H, Klein-Schwartz W. Time to Peak International Normalized Ratio Rise in Acute and Acute-on-Chronic Warfarin Overdoses. J Cardiovasc Pharmacol. 2021 Sep 1;78(3):474-479. doi: 10.1097/FJC.0000000000001070. PMID: 34516454.
* Afzal A, Gage BF, Suhong L, Schoen MW, Korenblat K, Sanfilippo KM. Different risks of hemorrhage in patients with elevated international normalized ratio from chronic liver disease versus warfarin therapy, a population-based retrospective cohort study. J Thromb Haemost. 2022 Jul;20(7):1610-1617. doi: 10.1111/jth.15743. Epub 2022 May 26. PMID: 35491428; PMCID: PMC9247029.
* Mittal P, Sayar Z, Cohen H. Warfarin and heparin monitoring in antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):192-199. doi: 10.1182/hematology.2024000547. PMID: 39644000; PMCID: PMC11665698.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.